Opinions & Advice

From due diligence and IP valuation to strategic advice and opinions of counsel, Sterne Kessler has the insights you need to proceed with confidence.

Related News & Insights

In the News

July 25, 2023

Teva Exits Cancer Drug IP Row With 2031 Generic License

Law360

Webinar

July 19, 2023 1:00 PM - 2:00 PM PST

Minimizing Your Risk of Being Sued Before the USITC

Webinar Recordings & Materials

July 19, 2023

Minimizing Your Risk of Being Sued Before the USITC